Stromal Caveolin-1 Is Associated With Response and Survival in a Phase II Trial of nab-Paclitaxel With Carboplatin for Advanced NSCLC Patients

In this phase II trial, carboplatin with nanoparticle albumin-bound (nab)-paclitaxel as first-line therapy for advanced non–small-cell lung cancer (NSCLC) was evaluated. Most patients had squamous cell histology. Tumor-associated stromal caveolin-1 (Cav-1) expression was correlated with improved res...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Clin Lung Cancer
Autors principals: Bertino, Erin M., Williams, Terence M., Nana-Sinkam, S. Patrick, Shilo, Konstantin, Chatterjee, Moumita, Mo, Xiaokui, Rahmani, Meliha, Phillips, Gary S., Villalona-Calero, Miguel A., Otterson, Gregory A.
Format: Artigo
Idioma:Inglês
Publicat: 2015
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5076571/
https://ncbi.nlm.nih.gov/pubmed/26123189
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cllc.2015.05.004
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars